JSM 2016 Online Program

Keyword Search

Sessions Were Renumbered as of May 19.

Legend:
CC-W = McCormick Place Convention Center, West Building,   CC-N = McCormick Place Convention Center, North Building
H = Hilton Chicago,   UC= Conference Chicago at University Center
* = applied session       ! = JSM meeting theme

Keyword Search Criteria: Drug combination returned 7 record(s)

Sunday, 07/31/2016

Two-Stage Design for Phase I/II Cancer Clinical Trials Using Drug Combinations of Cytotoxic Agents
Mourad Tighiouart, Cedars-Sinai Medical Center; Quanlin Li
2:25 PM

Monday, 08/01/2016

A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations in the Presence of a Baseline Covariate
Sungjin Kim; Mourad Tighiouart, Cedars-Sinai Medical Center; Marcio Diniz, Cedars-Sinai Medical Center

Bayesian Adaptive Designs Using Copula-Type Models in Phase I Cancer Trials Using Drug Combination
Galen Cook-Wiens, Cedars-Sinai Medical Center; Mourad Tighiouart, Cedars-Sinai Medical Center; Marcio Diniz, Cedars-Sinai Medical Center; Andre Rogatko, Cedars-Sinai Medical Center

Dose Finding for Drug Combination in Early Cancer Phase I Trials using Conditional Continual Reassessment Method
Quanlin Li; Mourad Tighiouart, Cedars-Sinai Medical Center; Marcio Diniz, Cedars-Sinai Medical Center

A New Design for Drug Combination in Phase I Dose-Finding Clinical Trials
Jim Xiang, Janssen; Grace Liu, Johnson & Johnson; James Pan, Janssen
9:35 AM

A Simple Bayesian Design to Identify Maximum Tolerated Dose Contour for Drug Combination Trials
Liangcai Zhang, Rice University; Ying Yuan, MD Anderson Cancer Center
2:20 PM

BOIN: A Simple, Ethical Bayesian Optimal Design for Phase I Oncology Trials
Ying Yuan, MD Anderson Cancer Center; Suyu Liu, MD Anderson Cancer Center
2:25 PM

JSM 2016 Online Program

Keyword Search

ASA Meetings Department

Share